Commentary on Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity
Clinical Chemistry · 2024
DOI: 10.1093/clinchem/hvae117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Chemistry, 2024. Verfasst von Mark A Cervinski. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, United States. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Sweat, Neonatal Screening, Chlorides. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, United States.
- The Geisel School of Medicine at Dartmouth, Hanover, NH, United States.
ORCID-Profile: Mark A Cervinski
Zitieren
APA
Cervinski, M. A. (2024). Commentary on Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvae117
Vancouver
Cervinski MA. Commentary on Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity. Clinical Chemistry. 2024. doi:10.1093/clinchem/hvae117
BibTeX
@article{Cervinski2024,
author = {Cervinski, Mark A},
title = {Commentary on Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity},
journal = {Clinical Chemistry},
year = {2024},
doi = {10.1093/clinchem/hvae117}
}
EUVIMED